Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2025-12-25 @ 4:10 AM
NCT ID:
NCT05023720
Eligibility Criteria:
1. Inclusion Criteria:
1. Must be a pathologically proven colorectal adenocarcinoma
2. Must have been treated with regorafenib
3. Regorafenib must be used after two lines of standard antitumor therapy
2. Exclusion Criteria:
1. Application is less than one course of treatment with regorafenib
2. First - or second-line treatment with regorafenib
3. Patients with multiple primary cancers
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05023720
Study Brief:
Protocol Section:
NCT05023720